Characterization of a Novel Protein with Homology to C-type Lectins Expressed by the Cotesia rubecula Bracovirus in Larvae of the Lepidopteran Host, Pieris rapae*

Richard Glatz, Otto Schmidt and Sassan Asgari {ddagger}

From the Department of Applied and Molecular Ecology, Waite Campus, The University of Adelaide, Glen Osmond, Adelaide, South Australia 5064, Australia

Received for publication, February 10, 2003 , and in revised form, March 17, 2003.
    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Polydnaviruses are essential for the survival of many Ichneumonoid endoparasitoids, providing active immune suppression of the host in which parasitoid larvae develop. The Cotesia rubecula bracovirus is unique among polydnaviruses in that only four major genes are detected in parasitized host (Pieris rapae) tissues, and gene expression is transient. Here we describe a novel C. rubecula bracovirus gene (CrV3) encoding a lectin monomer composed of 159 amino acids, which has conserved residues consistent with invertebrate and mammalian C-type lectins. Bacterially expressed CrV3 agglutinated sheep red blood cells in a divalent ion-dependent but Ca2+-independent manner. Agglutination was inhibited by EDTA but not by biological concentrations of any saccharides tested. Two monomers of ~14 and ~17 kDa in size were identified on SDS-PAGE in parasitized P. rapae larvae. The 17-kDa monomer was found to be an N-glyscosylated form of the 14-kDa monomer. CrV3 is produced in infected hemocytes and fat body cells and subsequently secreted into hemolymph. We propose that CrV3 is a novel lectin, the first characterized from an invertebrate virus. CrV3 shows over 60% homology with hypothetical proteins isolated from polydnaviruses in two other Cotesia wasps, indicating that these proteins may also be C-type lectins and that a novel polydnavirus lectin family exists in Cotesia-associated bracoviruses. CrV3 is probably interacting with components in host hemolymph, resulting in suppression of the Pieris immune response. The high similarity of CrV3 with invertebrate lectins, as opposed to those from viruses, may indicate that some bracovirus functions were acquired from their hosts.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Polydnaviruses are particles specifically associated with the ovaries of certain Braconid and Ichneumonid endoparasitoids (1). They are divided into genera, Ichnovirus and Bracovirus, based on differing host range and morphology (2). Polydnavirus genomes exist as a series of different circular DNA segments (3), which are packaged singly or in groups into individual polydnavirus particles (1). Particle-associated DNA segments are known to originate from wasp chromosomal DNA and are transferred in their integrated form to subsequent generations of wasps (4). Thus, polydnaviruses from different wasps are genetically isolated from each other and considered as separate "species" (5). "Transmission" of particles is exclusively vertical (4, 6), and particles are therefore not detected in males, although episomal polydnavirus DNA may exist (7).

Production of particles is restricted to specialized ovarian calyx cells (1) and is initiated in the pupal phase, soon after the onset of cuticular melanization, and continues in female adult wasps (8, 9, 10, 11). Although the replication mechanism is not completely understood, recent evidence suggests that controlled localized chromosomal amplification occurs before excision of the particle segments (10). Larger chromosomal segments may have smaller segments nested within (12). Particles accumulate in the oviduct and are injected into the host hemocoel, together with the parasitoid egg and various maternal secretions, at oviposition. The presence of polydnavirus particles is essential for survival of the egg and/or developing parasitoid larva (13, 14, 15).

Polydnavirus DNA segments do not contain genes for particle replication, so no particles are produced in the lepidopteran host (1, 16). Particles enter most host cell types (17, 18), and viral transcripts are produced in the first few hours after parasitization. Transcripts are generated either transiently (19) or persistently (17) during parasitism. Relative levels of Campoletis sonorensis ichnovirus gene expression in Helicoverpa virescens larvae depend largely on gene copy number (16); therefore, segment nesting could conceivably function to increase the copy number of genes essential for parasitoid survival. Such genes presumably would encode abundantly expressed, secreted proteins rather than intracellular proteins (16).

Cotesia rubecula bracovirus (CrBV)1 genes are expressed in the host larvae, Pieris rapae, over a relatively short time period, from 4 to 12 h after parasitization (19). CrBV appears to express only 4 major genes, which differs from other systems, such as C. sonorensis ichnovirus, which is suspected of expressing over 35 genes comprising several gene families (20). The products of particle-associated genes act to suppress the host immune response (19, 21, 22, 23, 24, 25), most often by targeting hemocytes. Gene products may also lead to physiological disorders (e.g. arrested development) by interfering with the host endocrine system (26, 27, 28, 29).

Suppression of the host immune response appears to be the primary function of most polydnavirus genes expressed in lepidopteran larvae and is considered an important evolutionary adaptation for an organism directly exposed to the immune system of its host. One of the four major CrBV genes, CrV1, encodes a glycoprotein that is abundantly expressed in host tissues and inactivates hemocytes by destabilizing the cytoskeleton (19, 30). As a result, infected hemocytes are unable to encapsulate the parasitoid egg. A 32-kDa wasp-specific protein (Crp32) produced in calyx cells is associated with particles and also covers the parasitoid's eggs, providing passive immune protection for the developing embryo (31). Whereas Crp32 appears to provide passive protection for the parasitoid, polydnavirus genes provide protection by actively suppressing host immune function. Both elements are required for survival and development of the C. rubecula parasitoid (31).

C-type lectins (CTLs) are proteins that bind to specific glycodeterminants and require the presence of divalent metal ions, most commonly Ca2+, to exhibit binding (32). CTLs are defined by a series of conserved residues in their carbohydrate recognition domains (CRDs) (33). Amino acid sequence differences in various CRDs produce a range of carbohydrate binding specificities. CTLs are extremely diverse and have been subdivided into seven groups based on gene structure and nature of non-lectin domains (32). One class, simple CTLs, has been isolated from invertebrates and appears to function as part of induced humoral immune responses (32), presumably binding to carbohydrates on the surface of foreign bodies or damaged tissue. These lectins are generally multimeric, with each monomer containing one CRD, and most often bind galactose as the primary ligand (33). Here we report on a novel CrBV gene, CrV3, the product of which shows divalent ion-dependent lectin activity and has a conserved CTL domain similar to those isolated from invertebrates and mammals. Although CTLs have been isolated from a range of invertebrates, this is the first report of a CTL associated with invertebrate viruses.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Insect Cultures—C. rubecula (Hymenoptera: Braconidae) endoparasitoid wasps were reared on cabbage-fed P. rapae (Lepidoptera: Pieridae) as described previously (34).

Virus and Genomic DNA Isolation—Calyx fluid from 50 female wasps was collected in PBS (138 mM NaCl, 2.7 mM KCl, 1.47 mM KH2PO4, and 7.3 mM Na2HPO4, pH 7.6) by homogenization of ovaries. The suspension was passed through a 0.45 µM syringe filter (Minisart®) and centrifuged at 15,800 x g in a desktop centrifuge for 15 min (35). Pelleted virus particles were resuspended in 180 µl of PBS, and DNA was isolated from this suspension as described previously (4). DNA was isolated from ovaries and female and male wasps by homogenizing them in a buffer made up of 10 mM Tris, 10 mM EDTA, and 1% SDS, pH 8.0. Proteinase K was added to a final concentration of 0.25 µg/µl, and the samples were incubated at 40 °C overnight. Samples were treated with RNase A (125 µg/µl) at 37 °C for 30 min and then extracted with phenol/chloroform. DNA was precipitated by adding 2 volumes of ethanol and 0.2 volume of 3 M sodium acetate, pH 5.3, and centrifugation at 15,800 x g for 20 min. Pellet was washed with 70% ethanol, dried at 37 °C, and resuspended in water.

Southern and Northern Hybridization—DNA samples were run on a 1% agarose gel and transferred to a nylon membrane (Amersham Biosciences) as described previously (36). Total RNA was isolated from 6 h parasitized P. rapae caterpillars according to Chomczynski and Sacchi (37). RNA samples were run on 1% agarose gels under denaturing conditions, using formaldehyde, and transferred to nylon membranes as described previously (36).

Construction and Screening of a 6 h Parasitized Larval P. rapae Library—Total RNA was extracted from P. rapae larvae at 6 h after parasitization by mated C. rubecula wasps (QuickPrepTM total RNA extraction kit; Amersham Biosciences). mRNA was then isolated from total RNA (PolyATtractTM mRNA isolation system; Promega). The isolated mRNA was used for construction of the cDNA library containing clones packaged in pBlueskript® SK(±) phagemids (cDNA synthesis kit, ZAP-cDNA® synthesis kit, and ZAP-cDNA® Gigapak® III Gold cloning kit; Stratagene). The library was amplified and titered according to the manufacturer's instructions before being probed with total CrBV DNA previously digested with BamHI and HindIII and labeled with 32P. Probes were prepared as described (Ready-To-GoTM DNA labeling beads; Amersham Biosciences). Positive clones were re-screened, resulting in isolation of the complete CrV3 coding region. CrV3 was sequenced using M13 forward and reverse primers directly from the phagemid vectors produced by the aforementioned protocols and subsequent automated sequencing (Applied Biosystems).

PCR Amplifications—Specific primers to the CrV3 open reading frame (5' primer CrV3-F and 3' primer CrV3-R; see Fig. 1A) were designed containing SphI and PstI restriction sites to allow for direct ligation of the amplified fragment into the pQE30 expression vector (Qiagen). Primer sequences were as follows (restriction sites are underlined): CrV3-F, CGCGGCATGCAAAAACATAAGCATTCAG; and CrV3-R, GCGCCTGCAGTCACTCCTTTGTGCAGAAG. Approximately 30 ng of genomic DNA from female C. rubecula wasps or 100–350 ng of plasmid DNA was used as template in PCR reactions. A 50-µl reaction was prepared by mixing 5 µl of 10x reaction buffer, 3 µl of MgCl2 (Promega), 1 µl of CrV3-F primer (0.1 µg/µl), 1 µl of CrV3-R (0.1 µg/µl), 0.5 µl of deoxynucleotide triphosphates (15 mM), and 0.5 µl of Taq DNA polymerase (Promega) and template DNA. After 5 min at 94 °C, 30 amplification cycles were run including denaturing at 94 °C for 1 min, annealing at 56 °C for 1 min, and extension at 72 °C for 1 min. Final extension was carried out for 5 min at 72 °C. Reaction products were electrophoresed on 1.2% agarose gels at 110 mA and visualized using ethidium bromide.



View larger version (48K):
[in this window]
[in a new window]
 
FIG. 1.
A, DNA nucleotide sequence and deduced amino acid sequence for CrV3 from the C. rubecula bracovirus (GenBankTM accession number AY234855 [GenBank] ). The putative signal peptide is boxed and contains a predicted methionine start codon as the first amino acid. The predicted signal peptide cleavage point is denoted with an arrowhead. Amino acids representing putative N-glycosylation sites are underlined. The stop codon is indicated by an asterisk, and the polyadenylation signal is in bold. CrV3-F and CrV3-R primer binding sites are double underlined and located at the 5' and 3' ends of the open reading frame, respectively. Intron nucleotides are in lower case letters. B, hydrophobicity profile of CrV3. Distribution of hydrophobic and hydrophilic domains was determined using ProtScale software. Amino acid positions are represented on the x axis, and a score of relative amino acid hydrophobicity is represented on the y axis. Positive scores indicate hydrophobic residues, and negative scores indicate hydrophilic residues. A highly hydrophobic domain predicted at the N terminus of CrV3 is consistent with a putative signal peptide at the same region.

 

Reverse Transcription-PCR (RT-PCR)—CrV3-F and CrV3-R primers were used in RT-PCR of RNA isolated from 6 h parasitized P. rapae larvae, utilizing avian myeloblastosis virus reverse transcriptase (Promega). 1.5 µg of RNA and 0.1 µg of CrV3-R primer, in a final volume of 10.7 µl, were heated to 95 °C for 5 min to denature RNA, before being cooled on ice. Reverse transcription was performed by adding 3 µl of 5x RT buffer (Promega), 0.3 µl of RNasin (Promega), 0.5 µl of avian myeloblastosis virus reverse transcriptase, and 0.5 µl of deoxynucleotide triphosphates (15 mM) before heating at 42 °C for 1 h and then heating at 95 °C for 5 min. The total contents were then used in a PCR by adding 3.5 µl of 10x reaction buffer, 1 µl of CrV3-F primer (0.1 µg/µl), 1 µl of CrV3-R (0.1 µg/µl), 0.5 µl of deoxynucleotide triphosphates (15 mM), 0.5 µl of Taq DNA polymerase, and 29 µl of H2O. Cycling, electrophores s, and visualization protocols were as performed for standard PCR of CrV3.

Collection of Protein Samples and Western Blotting—P. rapae larvae were bled into PBS saturated with phenylthiourea via removal of a proleg, and the hemolymph was centrifuged at 2300 x g for 5 min at room temperature. Supernatant (cell-free hemolymph) was removed, and the cellular pellet was resuspended in PBS. Gut tissue and head capsule were removed, and the fat body was washed and then homogenized in PBS before centrifugation (9300 x g for 10 min) and removal of supernatant (fat body proteins). Protein samples were stored at –20 °C and electrophoresed on denaturing 15% SDS-polyacrylamide gels as described by Laemmli (38). Proteins were generally not heated before electrophoresis unless testing the effect of heating. Samples were run in conjunction with SeeBlueTM pre-stained standard protein markers (Novex) to allow subsequent estimation of sample protein sizes. Proteins were either stained within the gels using Coomassie Blue (Sigma) or, alternatively, transferred to a nitrocellulose membrane (Amersham Biosciences) as described previously (36). Before obtaining anti-CrV3, blots were probed with a 1:10,000 dilution of an alkaline phosphatase-conjugated monoclonal anti-polyHistidine antibody (clone His-1; Sigma). Anti-CrV3 was used at a dilution of 1:5000 (see below).

Expression of CrV3 in Bacteria—Gene-specific primers were designed (CrV3-F and CrV3-R) to amplify the open reading frame of the CrV3 gene, excluding a putative signal sequence corresponding to the first 14 amino acids of the protein (see Fig. 1). These primers were used in PCR of phagemid vector produced during library screening to obtain the required fragment for ligation into the pQE30 bacterial expression vector (Qiagen). The desired PCR product was purified (Perfectprep® Gel Cleanup Kit; Eppendorf), precipitated, and digested with SphI and PstI, as was pQE30, before ligation of the digested DNAs using T4 DNA ligase (Promega). M15 strain of Escherichia coli was transformed with the ligation reaction contents, using heat shock. Colonies containing desired recombinant vectors were identified by PCR of bacterial cells using vector-specific primers. Production of bacterial CrV3 (containing 6 additional vector-derived histidine residues) was induced by the addition of 1 mM isopropyl-1-thio-{beta}-D-galactopyranoside to bacterial cultures before incubation for 2 h at 37 °C. The resultant fusion protein was identified by Western blotting and contained mainly in the insoluble fraction of total bacterial proteins, with only a small amount being soluble.

Purification of Insoluble Bacterial CrV3 Protein—50 ml of induced bacterial culture was centrifuged at ~7700 x g for 10 min at 4 °C. Cells were then resuspended in a lysis buffer (6 M GuHCl, 0.1 M NaH2PO4, and 0.01 M Tris, pH 8 .0) and gently rocked for 1 h. The sample was centrifuged at 12,000 x g for 15 min at 4 °C before incubation (1 h, RT) of the supernatant with 300 µl of nickel-nitrilotriacetic acid resin beads (Qiagen) previously equilibrated in 8 M urea (with 0.1 M NaH2PO4 and 0.01 M Tris, pH 8.0). Non-bound proteins were removed with buffers containing 8 M urea with pH > 6.3, and bound proteins were eluted with buffers containing 8 M urea with pH < 6.0. Samples were diluted with 2 volumes of water before being dialyzed overnight in Tris-buffered saline (0.15 M NaCl and 0.01 M Tris, pH 8.0) at 4 °C to remove excess urea to renature the protein. Protein was concentrated by vacuum drying.

Anti-CrV3 Antibody Production—Purified bacterial CrV3 was visualized on 15% SDS-acrylamide gels by staining with water-dissolved Coomassie Blue. CrV3 protein bands were excised from the gel with sterile blades and crushed. One rabbit was used to produce anti-CrV3 by an initial injection of the purified CrV3 (~5 µg) mixed with Freund's complete adjuvant (Sigma), followed by two booster injections with purified CrV3 with Freund's incomplete adjuvant (Sigma) at 2 and 4 weeks, respectively, after the initial injection. Antiserum was obtained 2 weeks after the final injection and used to probe Western blot membranes at a dilution of 1:5000. Bound anti-CrV3 was then visualized by alkaline phosphatase-labeled secondary anti-rabbit antibody (1:10,000).

N-Glycosidase Digestion of CrV3—Total proteins from cell-free hemolymph of 6 h parasitized P. rapae larvae were mixed with SDS-PAGE loading buffer containing {beta}-mercaptoethanol. Igepal CA-630 nonionic detergent (Sigma) was added to a final concentration of 0.8% before addition of 2 units of recombinant N-glycosidase F (Roche Diagnostics) and incubation for 18 h at 37 °C.

Characterization of CrV3-mediated Hemagglutination—Lectin activity was measured by mixing 25 µl of serially diluted bacterial CrV3 extract with 25 µl of 2% trypsinized and gluteraldehyde-stabilized ovine red blood cells (ORBCs; Sigma) in PBS containing 2% bovine serum albumin. Samples were mixed well in U-bottomed microtiter wells before incubation at 37 °C for 1 h. Complete agglutination caused ORBCs to form a diffuse layer over the bottom of the wells, whereas unagglutinated cells formed a small dot at the center of the wells. Lectin titer was determined as the reciprocal of the maximum sample dilution causing complete ORBC agglutination. To test for inhibitory ligands, 5 µl of sugar solution (various concentrations) in PBS was added before incubation in place of the 5 µl of PBS used to dilute ORBCs in the standard assay. Lipopolysaccaride (E. coli, serotype 055:B5A; Sigma) and Laminari tetrose were added as described for the other sugars, up to a maximum concentration of 1 mg/ml. Comparison of concentrations causing 50% inhibition of lectin activity was made for all sugars tested. To test for dependence of lectin activity on divalent cations, 25 µl of serial CrV3 sample dilutions was prepared in 1 mM divalent cations (Mg, Mn, and Ca) or 1 mM EDTA and mixed with 25 µl of 2% ORBCs as described above. Increasing concentrations of divalent cations were also added to EDTA-inhibited CrV3 to restore lectin activity.


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Molecular Characterization and Expression of CrV3—C. rubecula parasitoid wasps inject polydnavirus particles into the hemocoel of P. rapae larvae at oviposition, leading to infection of host tissues by the particles and transient expression of particle-associated genes (19). CrV1 was previously isolated by screening a cDNA library constructed from 6 h parasitized caterpillars using total CrBV DNA as a probe (19). The same method was used here to isolate a ~700-bp cDNA encompassing the coding region of a putative CrBV gene and including a poly(A) tail (Fig. 1A).

To confirm the cDNA as particle-derived, the fragment was cloned and used as a probe in both a Southern blot of digested CrBV DNA (Fig. 2A) and a Northern blot of RNA from unparasitized and 6 h parasitized larvae (Fig. 2B). Hybridization occurred to a CrBV restriction fragment of ~4 kb and to a parasitism-specific transcript of ~1.1 kb. These data and the fact that the same probe bound to genomic DNA from female wasps but not to that from P. rapae (data not shown) indicate that the cDNA originated from particles introduced to the larvae at oviposition.



View larger version (53K):
[in this window]
[in a new window]
 
FIG. 2.
A, Southern hybridization of 32P-labeled CrV3 cDNA to a ~4-kb EcoRI restriction fragment of CrBV DNA (CrBV). The corresponding gel is shown to the left. B, Northern hybridization utilizing 32P-labeled CrV3 cDNA fragment to probe total RNA extracted from non-parasitized (N) and 6 h parasitized (P) P. rapae larvae. Hybridization was to a parasitism-specific transcript of ~1.1 kb in size. Approximately 20 µg of RNA was loaded in each lane (see loading control at the bottom). C, Western blot analysis (15% SDS-PAGE; anti-polyHISTIDINE, 1:10,000) of total proteins from non-induced (T0) and 2 h induced (T2) recombinant M15 bacterial cells (containing partial CrV3 open reading frame) and bacterial CrV3 protein extract (C) purified from induced cells. D, Western blot analysis (15% SDS-PAGE; anti-CrV3 antiserum, 1:5000) of cell-free hemolymph from 6 h parasitized (P) and non-parasitized (N) P. rapae larvae. Parasitism-specific CrV3 monomers of ~17 and ~14 kDa in size are clearly visible (ratio, approximately 2:1). The arrowhead indicates a small amount of CrV3 dimer. E, RT-PCR of total RNA from cell-free hemolymph (C, negative control), hemocytes (H), and fat body (F) from 6 h parsasitized P. rapae larvae. Specific primers to the open reading frame of CrV3 (CrV3-F and CrV3-R) were utilized, resulting in detection of CrV3 transcript (arrowhead) in hemocytes and fat body. F, Western blot analysis (15% SDS-PAGE; anti-CrV3 antiserum, 1:5000) of cell-free hemolymph (C), hemocytes (H), and fat body (F) from 6 h parasitized P. rapae larvae. Note that most CrV3 is located in cell-free hemolymph, where the monomer ratio is the opposite of that in fat body.

 

Binding of the cDNA to only one site in the Northern blot reveals that CrV3 shows no significant nucleotide sequence homology with other CrBV-related genes. The cDNA was subsequently sequenced with data showing an open reading frame of 480 bp (Fig. 1A). A methionine codon (ATG) at the beginning of the open reading frame was identified as the only possible codon with a nucleotide sequence environment predicted for functional initiation codons (39). The predicted molecular mass of CrV3 is 17.6 kDa, with a pI of 9.13. Computer analyses (PSORT II; psort.nibb.ac.jp/form2.html) of the deduced amino acid sequence revealed a putative signal peptide encompassing the first 14 amino acids of the protein, with a cleavage point predicted at the end of the signal peptide (Fig. 1A), indicating that CrV3 protein is probably secreted from cells of origin. A hydrophobicity plot (Fig. 1B) was produced using ProtScale software (40). Highly hydrophobic residues near the N terminus support predictions of signal sequence composed of N-terminal amino acids. Three putative N-glycosylation sites were found in the open reading frame, as well as a polyadenylation signal ~150 bp downstream of the stop codon (Fig. 1A).

Sequence data were used to generate specific primers to the CrV3 open reading frame (CrV3-F and CrV3-R; see Fig. 1A). Comparison of RT-PCR and genomic DNA PCR products, utilizing these primers, revealed the presence of a 186-bp intron in the genomic CrV3 DNA. The intron was located within the conserved lectin domain. The CrV3 open reading frame (excluding the putative signal peptide) was cloned into pQE30 vector and used to transform Escherichia coli cells in which the CrV3 protein was subsequently induced. Analysis of Coomassie Blue-stained SDS-polyacrylamide gels containing proteins from non-induced and induced cells showed the presence of a ~16-kDa protein that was heavily up-regulated in induced cells and present mainly in the insoluble portion of the total bacterial proteins (data not shown). Nickel resin beads were used to purify the protein. Confirmation of purification of the up-regulated protein was achieved by using Western blot analysis with anti-polyHistidine as a probe (Fig. 2C).

Purified protein from the insoluble fraction was used for injection into rabbits and production of putative anti-CrV3 antibodies. Serum from injected rabbits was used to probe cell-free hemolymph from non-parasitized and 6 h parasitized P. rapae larvae. The serum hybridized to a parasitism-specific protein that was not recognized by rabbit pre-serum (data not shown), confirming successful production of anti-CrV3 antibodies. Western blots utilizing anti-CrV3 antibodies showed two CrV3-related monomers, which are present mainly in the cell-free hemolymph (Fig. 2, D and F). These monomers were approximately 17 and 14 kDa in size and were present in a ratio of approximately 2:1 as judged by the intensity of electrophoresed bands (Fig. 2, D and F). Treatment of cell-free hemolymph from 6 h parasitized larvae with a recombinant N-glycosidase resulted in removal of the larger monomer and an increase in the smaller monomer, suggesting that the larger monomer is an N-glycosylated form of the smaller monomer (Fig. 3, A and B). No putative O-glycosylation sites were predicted by computer analysis. Similar lectin monomers (differing by glycosylation) have been identified in Drosophila melanogaster (41), although the biological significance of glycosylation (or deglycosylation) of the Drosophila lectin is not understood.



View larger version (66K):
[in this window]
[in a new window]
 
FIG. 3.
Multimerization of CrV3. Anti-CrV3 antiserum (1:5000) was used in all Western analyses (15% SDS-PAGE). A and B, analysis of untreated (C) and N-glycosidae F-treated (N) proteins from cell-free hemolymph of 6 h parasitized P. rapae larvae. In both blots, the larger ~17-kDa monomer is deglycosylated such that it is identical to the smaller ~14-kDa monomer. Decreases in the size of CrV3 dimer (arrowhead in A) and tetramer (arrowhead in B) indicate that these multimers are also glycosylated. C, magnified view of untreated (C) and N-glycosidase F-treated (N) CrV3 tetramer bands. D, analysis of cell-free hemolymph from 6 h parsasitized P. rapae larvae, which was either left at room temperatute (PRT) or boiled for 10 min (P100) before electrophoresis. Heating resulted in dimer (lower arrowhead) denaturation into monomers and release of tetramer (upper arrowhead) from a putative larger complex. E and F, analysis of purified extract from induced bacteria containing empty plasmid or recombinant plasmid with CrV3 open reading frame. No CrV3-related molecules were detected in non-recombinant cells that were left at room temperature (BRT) or heated to 65 °C for 10 min (B65). CrV3 monomer and a range of multimers were detected in recombinant cells that were left at room temperature (CRT). Multimers were denatured into components when recombinant cells were heated at 65 °C for 10 min (C65). Boiling of CrV3 sample (C100) resulted in denaturation of a larger CrV3 complex, allowing detection of multimers not seen in the same amount of protein left at room temperature (CRT).

 

RT-PCR, utilizing primers from the CrV3 open reading frame, was used to test for production of CrV3 transcript in fat body and hemocytes from 6 h parasitized larvae (see Fig. 2E). These data indicate that CrV3 is produced by hemocytes and fat body cells. Western blot analysis, using anti-CrV3 antibodies, was performed on total proteins from larval fat body, hemocytes, and cell-free hemolymph at 6 h after parasitization (Fig. 2F). The presence of a large amount of CrV3 in the cell-free hemolymph compared with fat body or hemocytes confirms that the protein is secreted and possibly interacts with soluble hemolymph components. It appears that the relative amount of each CrV3 monomer varies with its location within parasitized larvae (Fig. 2F). In cell-free hemolymph, the ratio of 17-kDa monomer to 14-kDa monomer is usually 2:1 (see Fig. 2, D and F), whereas in fat body, the ratio is reversed (Fig. 2F). These data are consistent with CrV3 being secreted from fat body (and/or hemocytes) into the hemolymph because this is where most of the 17-kDa monomer is detected. The smaller monomer detected in fat body and hemocytes is probably intracellular. Presumably, only glycosylated monomers are secreted from infected cells before wasp or host elements remove N-glycosylated carbohydrates to produce the 14-kDa monomer. A similar phenomenon has been reported for the CrV1 protein, which has N-acetyl-D-galactosamine residues removed by Pieris hemolymph (30). CrV3 hemolymph concentration was at a maximum at ~6 h parasitization but was almost undetectable in hemolymph by Western analysis at 24 h parasitization (data not shown), an observation consistent with the transient expression of CrV3 (19).

Dimer and tetramer CrV3 molecules were detected in small amounts under denaturing conditions in parasitized larvae and were both shown to contain glycosylated monomers (Fig. 3, AC). The relative amount of different oligomers appeared to vary with individual larvae, and often only one type was detected (compare Figs. 2D and 3, A and B). The significance of this phenomenon is not clear. Boiling of cell-free hemolymph proteins from 6 h parasitized larvae resulted in an increase in CrV3 tetramers and a decrease in dimers (Fig. 3D). It seems likely that boiling denatures the dimers and releases the tetramers from a large complex formed with a soluble hemolymph component or CrV3 alone. CrV3 hexamers and smaller oligomers were detected in purified bacterial CrV3 under denaturing conditions (Fig. 3E). Heating bacterial CrV3 to 65 °C resulted in a breakdown of smaller multimers into their components. However, boiling resulted in an increase of all detectable multimers (Fig. 3F), indicating that the bacterial CrV3 is forming much larger homogeneous complexes that are denatured at temperatures near 100 °C. The observation that CrV3 appears to only form multimers that are multiples of dimers suggests that pre-formed CrV3 dimers are the minimum element required for polymerization. The fact that bacterial CrV3 forms multimers indicates that sugar residues are not required for dimerization/multimerization. These large complexes were probably not entering the acrylamide gel or were not transferred to the membrane. Formation of large multimers is characteristic of several of the invertebrate CTLs characterized previously (42, 43, 44, 45, 46).

Similarity of CrV3 and Known CTLs—Comparison of the deduced amino acid sequence with those from the GenBankTM revealed that CrV3 shows significant conservation with various C-type lectins. Significantly, key amino acids are conserved in CTLs from invertebrates and mammals that are also found in CrV3 sequence (Fig. 4A). Thus, sequence similarities suggest that CrV3 is a lectin whose activity is dependent on the presence of divalent metal ions. Interestingly, the highest levels of similarity are with hypothetical proteins from C. ruficrus and C. karyai bracoviruses (67% and 61%, respectively) (Fig. 4A), indicating that these proteins may also function as CTLs. The next closest lectins are lipopolysaccharide-binding proteins from Periplaneta americana and Bombyx mori, although sequence similarity with these lectins is approximately half that of the bracovirus lectins. CrV3 was also found to be similar to a suite of P. americana lectins (data not shown).



View larger version (64K):
[in this window]
[in a new window]
 
FIG. 4.
A, comparison of partial amino acid sequences in lectin domains of polydnavirus, insect, and mammalian CTLs. Homologous residues with CrV3 are boxed in black, and residues conserved among various CTLs are indicated by asterisks. B, comparison of complete amino acid sequences from CrV3 and hypothetical proteins from C. ruficrus and C. karyai bracoviruses. Indicators are as described for A. Sequences are from CrV3 (CrV3; GenBankTM accession number AY234855 [GenBank] ), C. ruficrus bracovirus hypothetical protein (CrufPDV; GenBankTM accession number BAC55179 [GenBank] ), C. karyai bracovirus hypothetical protein (CkarPDV; GenBankTM accession number BAC55180 [GenBank] ), B. mori lipopolysaccharide-binding protein (Bm; GenBankTM accession number CAB38429 [GenBank] ), P. americana hemolymph lipopolysaccharide-binding protein (Pa; GenBankTM accession number BAA00616 [GenBank] ), and Homo sapiens asialoglycoprotein receptor of hepatic lectin H1 (Hs; GenBankTM accession number NP00162).

 

It is of note that the Cotesia-associated polydnavirus lectins show greater similarity with invertebrate lectins compared with those of other viruses. Virus lectins are generally surface proteins that are involved in attachment of the virion to specific sugar determinants on target cells (47). However, polydnavirus particles enter host cells before lectin expression and probably express soluble lectins as part of immune suppression, a function much closer to that of induced humoral invertebrate lectins. CrV3 has a simple structure, consisting of only a signal peptide and CRD, another featured shared with several invertebrate lectins. No other functional domain appears to be present. The few known parasite or parasitoid lectins appear to show homology with host proteins that are important for immune responses against the parasite (48). It is conceivable that, having structural and sequence similarities to host lectins, CrV3 might compete with host lectins for binding sites that are involved in recognition or induction of the immune system. Sequence similarities between CrV3-like lectins and invertebrate lectins and similarities in parasite/host lectins support a hypothesis that some parasite genes originate from host genetic material.

CrV3 Lectin Activity: Hapten Sugars and Dependence on Divalent Metal Ions—Purified bacterial CrV3 agglutinated trypsinized and gluteraldehyde-fixed ovine red blood cells. Lectin activity was shown to be enhanced in the presence of 1 mM Mg2+ and Mn2+ but was independent of Ca2+ (Table I). Lectin activity was completely abolished in the presence of 1 mM EDTA and was restored by the addition of 0.5 mM Mg2+ or 1 mM Mn2+ but not by Ca2+ concentrations up to 5 mM. Surprisingly, this is in contrast to other described CTLs, which are invariably Ca2+-dependent. The effect of Mn2+ had a marked CrV3 concentration-dependent threshold, whereas the effect of Mg2+ gradually decreased as CrV3 levels were reduced (data not shown). This effect and the strong enhancement of agglutination by Mn2+ may indicate that Mn2+ may be important for tight regulation of CrV3 activity in vivo. It is possible that metal dependence of native CrV3 differs from that of recombinant protein.


View this table:
[in this window]
[in a new window]
 
TABLE I
Effect of addition of various 1 mM divalent cations or 1 mM EDTA on bacterial CrV3-mediated hemagglutination.

 

CrV3-mediated agglutination was not significantly inhibited by any of over 20 sugars tested at 100 mM (Table II). It would be expected that the hapten sugar should completely inhibit agglutination at concentrations near 1 mM. None of the common mono- and disaccharides were significantly inhibitory, a result that was not expected, given the relatively simple specificities of the closest vertebrate lectins (commonly binding galactose). To test the assay, lectin from Helix pomatia was used to agglutinate cells and was completely inhibited by its hapten sugar, N-acetyl-D-galactosamine (49). It is possible that bacterial CrV3 has altered specificity compared with wild-type CrV3 due to differences in post-translational modifications; however, this is unlikely, given that lectin activity is readily demonstrated by red blood cell aggregation and dependence on divalent ions. It seems more likely that CrV3 requires a complex sugar and/or amino acid residues for its binding or is highly discerning in relation to which sugar anomer is encountered or what accessory elements are attached to the basic sugar monomer. Amino acid residues on each side of the conserved proline (Pro126 in CrV3; Fig 4B) are known to be important determinants of carbohydrate specificity (33). The closest lectins to CrV3 mostly exhibit galactose-type binding and are characterized by the sequence Gln-Pro-Asn, whereas the equivalent CrV3 sequence is Lys125-Pro126-Ser127. Whereas other galactose-type binding lectins have a Ser residue following the conserved proline (33), as do the hypothetical bracovirus lectins, the occurrence of the preceding lysine residue in CrV3 is rare among such lectins. Thus, the unusual CrV3 sequence may possibly explain its Ca2+ independence and why simple galactose-derived sugars do not inhibit CrV3-mediated agglutination as expected and may indicate that CrV3 specificity is atypical. It is perhaps intuitive that CrV3 may have highly specific binding requirements because it presumably targets an individual element associated with host immunity. Lipopolysaccharide from E. coli (serotype 055:B5; Sigma) at 1 mg/ml also failed to significantly inhibit CrV3-mediated agglutination.


View this table:
[in this window]
[in a new window]
 
TABLE II
Effect of various potential ligands on bacterial CrV3-mediated hemagglutination

 

Preliminary in vitro experiments suggest that CrV3 may lessen the ability of healthy host hemocytes to spread on a foreign surface and may cause agglutination of these cells at high concentrations when present in the surrounding medium but does not seem to attach to these cells. It is possible that CrV3 interacts with a soluble hemolymph component that is required for activation of cellular defense. Without knowledge of CrV3 specificity, purification of native CrV3 to homogeneity from parasitized P. rapae larvae remains problematic.

In summary, the CrV3 gene from CrBV has conserved amino acid residues consistent with known CTLs from invertebrates and mammals, and the recombinant protein shows divalent ion-dependent lectin activity. However, this CTL is unique in that it does not require Ca2+ for its lectin activity. In addition, lectin activity was not inhibited by common carbohydrates, implying that it may be specific to non-carbohydrate ligands or may require an accessory component(s). CrV3 monomers are composed almost entirely of a single C-type CRD and appear to aggregate into multimers. Thus, we propose that CrV3 is a novel multimeric CTL expressed as part of CrBV infection of host larval tissues. The most probable function of CrV3 is to interact with host hemolymph components to lessen immune reactions against the developing parasitoid. Of the characterized CTLs, CrV3 shows highest similarity with lipopolysaccharide-binding proteins from insects. However, CrV3 appears homologous to hypothetical proteins isolated from bracoviruses associated with two other Cotesia wasps. Therefore, it seems likely that these hypothetical proteins will also function as lectins and may have similar metal ion dependence/binding specificity to CrV3. Furthermore, it appears that Cotesia-related bracoviruses express a novel polydnavirus gene family of closely related lectins. Other polydnavirus gene families have been identified (20), but no invertebrate virus protein has thus far been characterized as a CTL. Much debate exists as to the ancestral form of polydnaviruses. The bracovirus lectins may be important for evolutionary studies and appear to support a hypothesis that a bracovirus was present in a common Cotesia ancestor and that some bracovirus genes originated from their insect hosts. Further research will aim to determine the CrV3 binding specificity, obtain purified native CrV3, and determine its mode of action.


    FOOTNOTES
 
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY234855 [GenBank] .

* This work was supported by the Australian Research Council and a University of Adelaide grant (to S. A.) and an Australian Postgraduate Award Ph.D. scholarship (to R. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed. Tel.: 618-8303-6565; Fax: 618-8379-4095; E-mail: sassan.asgari{at}adelaide.edu.au.

1 The abbreviations used are: CrBV, Cotesia rubecula bracovirus; CTL, C-type lectin; CRD, carbohydrate recognition domain; PBS, phosphate-buffered saline; RT, reverse transcription; ORBC, ovine red blood cell. Back


    ACKNOWLEDGMENTS
 
We thank MeiRong Zhang (Institute of Crop Genetics, Shanxi, China) for assistance in library screening during her stay in our laboratory.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Stoltz, D. B., and Vinson, S. B. (1979) Adv. Virus Res. 24, 125–171[Medline] [Order article via Infotrieve]
  2. Stoltz, D. B., and Whitfield, J. B. (1992) J. Hym. Res. 1, 125–139
  3. Krell, P. J., Summers, M. D., and Vinson, S. B. (1982) J. Virol. 43, 859–870
  4. Stoltz, D. B., Guzo, D., and Cook, D. (1986) Virology 155, 120–131[Medline] [Order article via Infotrieve]
  5. Webb, B. A. (1998) in The Insect Viruses (Miller, L. K., and Ball, L. A., eds), pp. 105–139, Plenum Publishing Corp., New York
  6. Stoltz, D. B. (1990) J. Gen. Virol. 71, 1051–1056[Abstract]
  7. Fleming, J. G., and Summers, M. D. (1986) J. Virol. 57, 552–562
  8. Norton, W. N., and Vinson, S. B. (1983) Cell Tissue Res. 231, 387–398[Medline] [Order article via Infotrieve]
  9. Albrecht, U., Wyler, T., Pfisterwilhelm, R., Gruber, A., Stettler, P., Heiniger, P., Kurt, E., Schumperli, D., and Lanzrein, B. (1994) J. Gen. Virol. 75, 3353–3363[Abstract]
  10. Pasquier-Barre, F., Dupuy, C., Huguet, E., Monteiro, F., Moreau, A., Poirié, M., and Drezen, J.-M. (2002) J. Gen. Virol. 83, 2035–2045[Abstract/Free Full Text]
  11. Tanaka, K., Matsumoto, H., and Hayakawa, Y. (2002) Appl. Entomol. Zool. 37, 323–328
  12. Cui, L., and Webb, B. A. (1997) J. Virol. 71, 8504–8513[Abstract]
  13. Edson, K. M., Vinson, S. B., Stoltz, D. B., and Summers, M. D. (1981) Science 211, 582–583[Medline] [Order article via Infotrieve]
  14. Stoltz, D. B., and Guzo, D. (1986) J. Insect Physiol. 32, 377–388[CrossRef]
  15. Guzo, D., and Stoltz, D. B. (1987) J. Insect Physiol. 33, 19–31
  16. Webb, B. A., and Cui, L. W. (1998) J. Insect Physiol. 44, 785–793[CrossRef][Medline] [Order article via Infotrieve]
  17. Strand, M. R., Mckenzie, V., Grassl, B. A., and Aiken, J. M. (1992) J. Gen. Virol. 73, 1627–1635[Abstract]
  18. Harwood, S. H., and Beckage, N. E. (1994) Insect Biochem. Mol. Biol. 24, 685–698[CrossRef]
  19. Asgari, S., Hellers, M., and Schmidt, O. (1996) J. Gen. Virol. 77, 2653–2662[Abstract]
  20. Turnbull, M., and Webb, B. (2002) Adv. Virus Res. 58, 203–254[Medline] [Order article via Infotrieve]
  21. Strand, M. R., and Noda, T. (1991) J. Insect Physiol. 37, 839–850
  22. Li, X., and Webb, B. A. (1994) J. Virol. 68, 7482–7489[Abstract]
  23. Lavine, M. D., and Beckage, N. E. (1996) J. Insect Physiol. 42, 41–51[CrossRef]
  24. Luckhart, S., and Webb, B. A. (1996) Dev. Com. Immunol. 20, 1–21[CrossRef][Medline] [Order article via Infotrieve]
  25. Cui, L., Soldevila, A., and Webb, B. A. (1997) Arch. Insect Biochem. Physiol. 36, 251–271[CrossRef][Medline] [Order article via Infotrieve]
  26. Vinson, S. B., and Iwantsch, G. F. (1980) Q. Rev. Biol. 55, 143–165
  27. Webb, B. A., and Dahlman, D. L. (1986) J. Insect Physiol. 32, 339–345
  28. Lawrence, P. O., and Lanzrein, B. (1993) in Parasites and Pathogens of Insects (Beckage, N. E., Thompson, S. N., and Federici, B. A., eds) Vol. 1, pp. 59–86, Academic Press, CA
  29. Balgopal, M. M., Dover, B. A., Goodman, W. G., and Strand, M. R. (1996) J. Insect Physiol. 42, 337–345[CrossRef]
  30. Asgari, S., Schmidt, O., and Theopold, U. (1997) J. Gen. Virol. 78, 3061–3070[Abstract]
  31. Asgari, S., Theopold, U., Wellby, C., and Schmidt, O. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 3690–3695[Abstract/Free Full Text]
  32. Kilpatrick, D. C. (2002) Biochim. Biophys. Acta 1572, 187–197[Medline] [Order article via Infotrieve]
  33. Drickamer, K., and Taylor, M. E. (1993) Rev. Cell Biol. 9, 237–264[CrossRef]
  34. Asgari, S., and Schmidt, O. (1994) J. Insect Physiol. 40, 789–795
  35. Beckage, N. E., Tan, F. F., Schleifer, K. W., Lane, R. D., and Cherubin, L. L. (1994) Arch. Insect Physiol. Biochem. 26, 165–195
  36. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  37. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156–159[CrossRef][Medline] [Order article via Infotrieve]
  38. Laemmli, U. K. (1970) Nature 227, 680–685[Medline] [Order article via Infotrieve]
  39. Cavener, R. C., and Ray, S. C. (1991) Nucleic Acids Res. 19, 3185–3192[Abstract]
  40. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105–132[Medline] [Order article via Infotrieve]
  41. Haq, S., Kubo, T., Kurata, S., Kobayashi, A., and Natori, S. (1996) J. Biol. Chem. 271, 20213–20218[Abstract/Free Full Text]
  42. Marchalonis, J., and Edelman, G. (1968) J. Mol. Biol. 32, 453–465[Medline] [Order article via Infotrieve]
  43. Giga, Y., Sutoh, K., and Ikai, A. (1985) Biochemistry 8, 2629–2705
  44. Kubo, T., and Natori, S. (1987) Eur. J. Biochem. 168, 75–82[Abstract]
  45. Muramoto, K., and Kamiya, H. (1990) Biochim. Biophys. Acta 1039, 42–51[Medline] [Order article via Infotrieve]
  46. Saito, T., Hatada, M., Iwanaga, S., and Kawabata, S. (1997) J. Biol. Chem. 272, 30703–30708[Abstract/Free Full Text]
  47. Sharon, N., and Lis, S. (1989) Lectins, Chapman & Hall, London
  48. Loukas, A., and Maizels, R. (2000) Parasitol. Today 16, 333–339[CrossRef][Medline] [Order article via Infotrieve]
  49. Hammarström, S., and Kabat, E. (1971) Biochemistry 10, 1684–1692[Medline] [Order article via Infotrieve]